Učitavanje...

A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of 2 and 4 Weeks of Twice-Daily Ocular Trabodenoson in Adults with Ocular Hypertension or Primary Open-Angle Glaucoma

Purpose: To evaluate the safety and ocular hypotensive efficacy of 4 trabodenoson doses administered twice daily over 14 or 28 days in subjects with ocular hypertension or primary open-angle glaucoma (POAG). Methods: In this multicenter, randomized, double-masked, placebo-controlled, dose-escalation...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Ocul Pharmacol Ther
Glavni autori: Myers, Jonathan S., Sall, Kenneth N., DuBiner, Harvey, Slomowitz, Natanya, McVicar, William, Rich, Cadmus C., Baumgartner, Rudolf A.
Format: Artigo
Jezik:Inglês
Izdano: Mary Ann Liebert, Inc. 2016
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5069706/
https://ncbi.nlm.nih.gov/pubmed/27002298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jop.2015.0148
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!